Eslicarbazepine Acetate Well Tolerated, Effective in Post-Stroke Epilepsy
Eslicarbazepine acetate is well tolerated and may be effective for treating patients with post-stroke epilepsy.
AES 2018
Long-Term Effectiveness of Adjunctive Brivaracetam For Previously Treated Focal Seizures
Adjunctive brivaracetam may provide long term effectiveness in adults who have not seen optimal results with other common treatments.
Generic Lamotrigine, Levetiracetam Formulations Comparable to Brand Name AEDs
Bioequivalent generic formulations of 2 antiepileptic medications were comparable to brand name treatments for new-onset epilepsy.
Fenfluramine Improves Emotion and Behavior Regulation in Pediatric Dravet Syndrome
Children with Dravet syndrome receiving fenfluramine experienced improvements in emotional regulation, behavioral regulation, and planning and organization abilities.
Psychiatric Adverse Effects from Levetiracetam Linked to Certain Factors
Researchers aimed to identify risk factors associated with a psychiatric event following a first prescription for levetiracetam.
SSRIs, TCAs, Antipsychotics Decrease Seizure Frequency in the Epilepsy Monitoring Unit
Patients taking an active treatment regimen consisting of SSRIs, TCAs, or antipsychotic medications are less likely to experience a seizure in the epilepsy monitoring unit.
Does the Ketogenic Diet Prevent Relapse in Infantile Spasms?
The classic ketogenic diet may not have a significant impact on preventing shttp://cms.haymarketmedia.com/Images/find.gifeizure occurrence in patients with infantile spasms of unknown etiology.
Eslicarbazepine Acetate Dose and ADRs Across Weight Groups Examined
Individual treatment-emergent adverse events (TEAE) did not increase with higher modal daily dose of eslicarbazepine acetate in pediatric patients with focal seizures.
Positive Retention Rates and Sustained Efficacy With Perampanel in Epilepsy
Perampanel at a median maximum dose of 6 mg (1 to 20 mg) is associated with good long-term treatment retention and sustained efficacy.
Enzyme-Inducing Antiepileptic Drugs Increase Vitamin D Requirements in Epilepsy
Investigators aimed to determine whether utilization of enzyme-inducing antiepileptic drugs increases vitamin D requirements.
Next post in AES 2018 Coverage
